Dusseldorf - Delayed Quote • EUR Virbac SA (V16.DU) Follow Compare 319.50 +4.00 +(1.27%) At close: January 10 at 8:11:22 AM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Virbac : Declaration of the number of shares and voti DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsDecember, 31 20248 390 660Gross total of voting rights : 12 707 315Net total* of Virbac : Declaration of the number of shares and voting rights 11/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsNovember, 30 20248 390 660Gross total of voting rights : 12 707 824Net total* of Virbac: Türkiye: Virbac acquires its companion animal distributor On December 2, we finalized the acquisition of Turkish company Mopsan, specialized in the distribution of petfood and companion animal health products. Present in Türkiye for over 20 years via various local distributors, then with our own subsidiary since 2018, we are today taking a new step forward with the acquisition of our companion animal products distributor: Mopsan. Working alongside Turkish veterinarians for over 30 years, Mopsan has extensive experience in the petfood and companion anim Virbac (ENXTPA:VIRP) Raises 2024 Earnings Guidance, Eyes Growth with Acquisitions and Market Expansion Virbac(ENXTPA:VIRP) has recently raised its earnings guidance for fiscal year 2024, anticipating net revenue growth between 12.5% and 14.5%, bolstered by strategic acquisitions of Globion and Sasaeah. Despite impressive financial performance, including a 14% annual earnings growth over five years, the company faces challenges with a forecasted return on equity below the French market average and competitive pressures necessitating strategic adjustments. In the following discussion, we will... Virbac : Declaration of the number of shares and voting rights 10/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsOctober, 31 20248 390 660Gross total of voting rights : 12 707 824Net total* of Virbac: Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained. KEY FIGURES Revenue at the end of September €1 042.1M Growth at constant exchange rates and scope1 +8.6% includingcompanion animals +11.9% farm animals +3.2% Growth at constant exchange rates2 +14.0% Overall change +12.6% 1growth at constant exchange rates and scope corresponds to organic growth of sales, excluding exchange rate variations, by calculating the indicator for the financial year in question and the indicator for the previous financial year on the basis of identical exchange rates (t Virbac : Declaration of the number of shares and voting rights 09/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsSeptember, 30 20248 390 660Gross total of voting rights : 12 708 271Net total* o Virbac SA (FRA:V16) (Q2 2024) Earnings Call Transcript Highlights: Strong Organic Growth and ... Virbac SA (FRA:V16) reports robust financial results with significant contributions from recent acquisitions and strategic investments. Virbac: erratum short Press release Capital reduction_September 13, 2024 This press release rectifies the version of the press release issued by Virbac on September 13, 2024 at 5:45 pm in order to correct a typing error in the amount of Virbac's new share capital. The share capital of Virbac amounts now to €10,488,325 and not €10,448,325 as announced. Focusing on animal health, from the beginningAt Virbac, we provide innovative solutions to veterinarians, farmers and animal owners in more than 100 countries around the world. Covering more than 50 species, our range o Virbac 2024 half-year results Exceptional business momentum in the first half, with revenue up 16.1% at constant exchange ratesStrong growth in adjusted current operating income1 +3.4 points compared with 2023 to reach a record level at 21.4% of revenue 2024 targets confirmed Revenue growth expected between 7% and 9% at constant exchange rates and scopeAdjusted current operating income1 expected to be around 16% compared with 15.1% in 2023 CONSOLIDATED FIGURES AS AT JUNE 30in € million 2024 2023 2024/2023 change Revenue 702. Virbac: Information on the departure of Sébastien Huron At its meeting on September 13, 2024, the board of directors acknowledged the resignation of Sébastien Huron, effective as of September 27, 2024, from his positions as chief executive officer of Virbac and director of Virbac Limited (UK). On the recommendation of the appointments and compensation committee, the board of directors has decided on the financial terms of Sébastien Huron's departure, as set out below. Fixed compensation for 2024 In accordance with the compensation policy approved by Virbac : the board of directors announces a capital reduction through cancellation of treasury shares During the meeting held on September 13, 2024, the board of directors, acting on the authorization granted by the combined shareholders’ meeting on June 20, 2023, decided to reduce the share capital of Virbac by canceling 67,340 treasury shares. These shares were acquired during 2023 under the share buyback program authorized by the same shareholders’ meeting. As of today, the share capital of Virbac amounts to €10,448,325, represented by 8,390,660 shares of €1.25, fully paid-up. Following this Virbac : Declaration of the number of shares and voting rights 08/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsAugust, 31 20248 458 000Gross total of voting rights : 12 776 794Net total* of v Virbac : Declaration of the number of shares and voting rights 07/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsJuly, 31 20248 458 000Gross total of voting rights : 12 776 794Net total* of vot VIRBAC: exceptional first-half momentum (+16.2% at constant exchange rates) driven by all regions KEY FIGURES Revenue in first half of 2024 €703.1M Growth at constant exchange rates and scope1 +11.3% includingcompanion animals +15.1% farm animals +7.0% Growth at constant exchange rates2 +16.2% Overall change +15.2% 1growth at constant exchange rates and scope corresponds to organic growth of sales, excluding exchange rate variations, by calculating the indicator for the financial year in question and the indicator for the previous financial year on the basis of identical exchange rates (the Virbac: Termination of the liquidity contract TERMINATION OF THE LIQUIDITY CONTRACT We inform you of the termination of our liquidity contract since July 1st, 2024. This contact was in place since February 19, 2019 and suspended since February 3rd, 2023. A lifelong commitment to animal healthAt Virbac, we provide innovative solutions to veterinarians, farmers and animal owners in more than 100 countries around the world. Covering more than 50 species, our range of products and services enables us to diagnose, prevent and treat the majority VIRBAC announces executive management changes Sébastien Huron leaves the company, Habib Ramdani takes over while the Group recruits its next chief executive officer Virbac announces the resignation of Sébastien Huron from his position as chief executive officer. He will leave the Virbac Group's executive management by September 30, 2024, to take a break from his professional life. The board of directors has decided to appoint Habib Ramdani, currently chief financial officer and deputy chief executive officer, as interim CEO, to replace Séba Virbac : Declaration of the number of shares and voting rights 06/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsJune, 30 20248 458 000Gross total of voting rights : 12 777 715Net total* of vot Virbac finalizes minority shares’ acquisition of Globion, an Indian poultry vaccines specialist On June 21, we finalized the acquisition of Globion's minority shares, bringing our stake to 100%. As planned, this transaction follows the acquisition of a 74% majority stake concluded on November 1, 2023. Founded in 2005, as a joint venture between Suguna Group, one of the leading Indian poultry conglomerates, and Lohmann Animal Health, a German poultry vaccines specialist, Globion has developed robust know-how and expertise in the development, manufacturing and commercialization of live and i Virbac : Declaration of the number of shares and voting rights 05/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsMay, 31 20248 458 000Gross total of voting rights : 12 777 598Net total* of voti Performance Overview Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is CAC 40 Return V16.DU CAC 40 YTD +2.57% +1.61% 1-Year -7.58% +0.06% 3-Year -17.59% +2.93%